Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unraveling the Spectrum of Migraine Resistant to Treatments: Searching for Novel Biological PHEnotypes and theRApeutic Approaches (SPHERA Project)

NCT06549270 is registered in ClinicalTrials.gov with IRCCS National Neurological Institute "C. Mondino" Foundation as lead sponsor.

NCT NCT06549270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unraveling the Spectrum of Migraine Resistant to Treatments: Searching for Novel Biological PHEnotypes and theRApeutic Approaches (SPHERA Project)
Lead sponsor
IRCCS National Neurological Institute "C. Mondino" Foundation
Phase
Observational
Overall status
Recruiting
Start date
May 10, 2023
Completion date
May 31, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic migraine, episodic migraine, migraine disorders